Lv1
10 积分 2024-09-20 加入
A Dynamic DNA Nano‐Antioxidant Targeting Galectin‐3 Attenuates Liver Fibrosis via Reducing Macrophage Oxidative Stress
1个月前
已完结
Tetrahedral framework nucleic acids ameliorate cholestatic liver disease by activating Wnt/β-catenin signaling and promoting ERK1/2 phosphorylation
1个月前
已完结
Oral Administration of a Tetrahedral Framework DNA-Based Nanoshot Attenuates Liver Fibrosis via Targeting Galectin3
1个月前
已完结
Oral Administration of a Tetrahedral Framework DNA-Based Nanoshot Attenuates Liver Fibrosis via Targeting Galectin-3
3个月前
已完结
Flavonoids-based nanomedicines for the treatment of liver fibrosis: A recent progress
6个月前
已完结
pPB Peptide-Mediated siRNA-Loaded Stable Nucleic Acid Lipid Nanoparticles on Targeting Therapy of Hepatic Fibrosis
6个月前
已完结
Two Trials of Therapeutics for MASH with Liver Fibrosis
6个月前
已完结
Collagenase Type I and Probucol-Loaded Nanoparticles Penetrate the Extracellular Matrix to Target Hepatic Stellate Cells for Hepatic Fibrosis Therapy
6个月前
已完结
Delivery Strategy to Enhance the Therapeutic Efficacy of Liver Fibrosis via Nanoparticle Drug Delivery Systems
6个月前
已完结
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
7个月前
已完结
皖公网安备34019202002308
